Cargando…
Possible inhibitory effects of terbinafine on aripiprazole metabolism: Two case reports
Aripiprazole, an atypical antipsychotic, is a metabolic substrate for cytochrome P450 (CYP)3A4 and 2D6. Terbinafine, an antifungal agent used for onychomycosis, is a CYP2D6 inhibitor and could theoretically reduce the metabolism of aripiprazole. However, there are no published reports describing thi...
Autores principales: | McGrane, Ian R., Lindbloom, Tori J., Munjal, Robert C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463003/ https://www.ncbi.nlm.nih.gov/pubmed/34621606 http://dx.doi.org/10.9740/mhc.2021.09.297 |
Ejemplares similares
-
Successful bilateral electroconvulsive therapy in a patient with a seizure disorder taking levetiracetam, lorazepam, and zonisamide: A case report
por: McGrane, Ian R., et al.
Publicado: (2021) -
Possible exercised-induced rhabdomyolysis associated with terbinafine
por: Bui, Peter V, et al.
Publicado: (2019) -
Pancreatitis with a Normal Serum Lipase, a Rare Post-esophagogastroduodenoscopy Complication: A Case Report
por: Sturlis, Molly, et al.
Publicado: (2022) -
Use of Aripiprazole in Clozapine Induced Enuresis: Report of Two Cases
por: Lee, Myung-Ji, et al.
Publicado: (2010) -
Development of Parkinsonism following exposure to aripiprazole: two case reports
por: Lua, Lannah L, et al.
Publicado: (2009)